Scientific Advisory Board
Integrated Drug Discovery
Disease Based Models
World Pharma News
ChemDiv and Abbott expand collaboration to develop branded generic pharmaceuticals for high growth emerging markets
January 14th, 2016 – The Chemical Diversity Research Institute of ChemDiv, Inc (ChemDiv), San Diego, CA – based global research ...
ChemDiv Announces Achievement of a Development Milestone in a Drug Discovery Collaboration With Janssen
SAN FRANCISCO, CA--(Marketwired - Jan 11, 2016) - J.P. Morgan 34th Annual Healthcare Conference -- ChemDiv, Inc. of San Diego, ...
2015 Chinese Medicinal Chemistry Symposium(CMCS2015) 5th CPA-RSC Symposium on Medicinal Chemistry in August
CMCS & China-UK JSMC) is one of the most influential events in the field of Medicinal chemistry in China. This ...
IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
WILMINGTON, Del.--(BUSINESS WIRE)--July 13, 2015. AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has approved IRESSA® (gefitinib) ...